The guide outlines actions health systems, health plans and clinicians can take to expand the use of MAT for patients with opioid use disorder.
“Many of the current barriers that prohibit clinicians from implementing MAT are organizational and consequently require executive-level support from healthcare delivery systems and healthcare insurers alike,” NQF wrote in a news release.
The guide was created based on feedback from a diverse group of stakeholders, including patients, administrators, insurers and addiction treatment center staff members.
To learn more about the guide, click here.
More articles on clinical leadership and infection control:
Meet SPOT: HCA Healthcare’s ‘smoke detector’ for sepsis
New York judge maintains ban on religious exemption to vaccine laws
OHSU heart transplant deaths rose before program shut down
